Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Molecular Pharmaceutics|August 27, 2014
Peptides used in the delivery of small noncoding RNARavi S Shukla, Bin Qin, Kun ChengNanomedicine : Nanotechnology, Biology, and Medicine|March 13, 2016
Intracellular trafficking and exocytosis of a multi-component siRNA nanocomplexRavi S Shukla, Akshay Jain, Zhen Zhao, et al.Pharmaceutical Research|May 26, 2011
Identification of a LNCaP-specific binding peptide using phage displayBin Qin, Wanyi Tai, Ravi S Shukla, et al.Molecular Pharmaceutics|April 23, 2011
Development of a peptide-drug conjugate for prostate cancer therapyWanyi Tai, Ravi S Shukla, Bin Qin, et al.Molecular Pharmaceutics|October 29, 2013
Development of streptavidin-based nanocomplex for siRNA deliveryRavi S Shukla, Wanyi Tai, Rubi Mahato, et al.Pharmaceutical Research|June 7, 2011
PCBP2 siRNA reverses the alcohol-induced pro-fibrogenic effects in hepatic stellate cellsRavi S Shukla, Bin Qin, Yu-Jui Yvonne Wan, et al.Vaccine|May 17, 2017
Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidateAshaben Patel, Steven M Erb, Linda Strange, et al.Journal of Pharmaceutical Sciences|October 9, 2020
Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral DeliveryPrashant Kumar, Swathi R Pullagurla, Ashaben Patel, et al.Human Vaccines & Immunotherapeutics|April 16, 2021
Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countriesPrashant Kumar, Ravi S Shukla, Ashaben Patel, et al.Pageof 1